Koninklijke Philips Shares Outstanding 2012-2025 | PHG
Koninklijke Philips shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Koninklijke Philips shares outstanding for the quarter ending September 30, 2025 were 0.964B, a 2.34% increase year-over-year.
- Koninklijke Philips 2024 shares outstanding were 0.933B, a 1.74% increase from 2023.
- Koninklijke Philips 2023 shares outstanding were 0.917B, a 4.06% increase from 2022.
- Koninklijke Philips 2022 shares outstanding were 0.882B, a 3.08% decline from 2021.
|
Koninklijke Philips Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 933 |
| 2023 | 917 |
| 2022 | 882 |
| 2021 | 910 |
| 2020 | 917 |
| 2019 | 913 |
| 2018 | 936 |
| 2017 | 945 |
| 2016 | 929 |
| 2015 | 924 |
| 2014 | 923 |
| 2013 | 922 |
| 2012 | 927 |
| 2011 | 956 |
|
Koninklijke Philips Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 964 |
| 2025-06-30 | 957 |
| 2025-03-31 | 938 |
| 2024-09-30 | 944 |
| 2024-06-30 | 942 |
| 2023-06-30 | 947 |
| 2023-03-31 | 882 |
| 2022-06-30 | 884 |
| 2021-06-30 | 913 |
| 2020-06-30 | 914 |
| 2019-06-30 | 914 |
| 2018-06-30 | 929 |
| 2017-06-30 | 940 |
| 2016-12-31 | 929 |
| 2016-09-30 | 931 |
| 2016-06-30 | 918 |
| 2016-03-31 | 925 |
| 2015-12-31 | 924 |
| 2015-09-30 | 928 |
| 2015-06-30 | 915 |
| 2015-03-31 | 918 |
| 2014-12-31 | 923 |
| 2014-09-30 | 928 |
| 2014-06-30 | 917 |
| 2014-03-31 | 926 |
| 2013-12-31 | 922 |
| 2013-09-30 | 922 |
| 2013-06-30 | 916 |
| 2013-03-31 | 920 |
| 2012-12-31 | 927 |
| 2012-09-30 | 936 |
| 2012-06-30 | 927 |
| 2012-03-31 | 927 |
| 2011-12-31 | 939 |
| 2011-09-30 | 962 |
| 2011-06-30 | 970 |
| 2011-03-31 | 958 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $29.051B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $214.803B | 24.76 |
| EssilorLuxottica (ESLOY) | France | $151.023B | 0.00 |
| Stryker (SYK) | United States | $138.625B | 27.52 |
| Boston Scientific (BSX) | United States | $133.464B | 30.52 |
| Medtronic (MDT) | Ireland | $126.919B | 17.58 |
| Medline (MDLN) | United States | $56.109B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.167B | 0.00 |
| Agilent Technologies (A) | United States | $41.059B | 25.95 |
| ResMed (RMD) | United States | $38.047B | 26.33 |
| GE HealthCare Technologies (GEHC) | United States | $37.585B | 17.98 |
| Terumo (TRUMY) | Japan | $20.817B | 23.43 |
| Insulet (PODD) | United States | $20.154B | 62.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.589B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.974B | 0.00 |
| Baxter (BAX) | United States | $10.471B | 8.45 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.688B | 31.24 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.338B | 13.22 |
| BillionToOne (BLLN) | United States | $4.335B | 0.00 |
| Envista Holdings (NVST) | United States | $4.060B | 23.29 |
| ICU Medical (ICUI) | United States | $3.829B | 24.31 |
| Haemonetics (HAE) | United States | $3.464B | 15.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.155B | 14.39 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.403B | 15.45 |
| Perrigo (PRGO) | Ireland | $2.088B | 5.23 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| Neogen (NEOG) | United States | $2.058B | 45.05 |
| LeMaitre Vascular (LMAT) | United States | $1.962B | 39.50 |
| Curaleaf Holdings (CURLF) | Canada | $1.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.715B | 75.18 |
| Phibro Animal Health (PAHC) | United States | $1.624B | 16.22 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.459B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Kestra Medical Technologies (KMTS) | United States | $1.341B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 349.57 |
| Capricor Therapeutics (CAPR) | United States | $1.099B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.090B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.944B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 10.04 |
| Omeros (OMER) | United States | $0.866B | 0.00 |
| Valneva SE (VALN) | France | $0.865B | 0.00 |
| CeriBell (CBLL) | United States | $0.847B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.75 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.452B | 77.00 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.371B | 0.00 |
| Evolus (EOLS) | United States | $0.324B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 22.85 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.196B | 1.96 |
| Utah Medical Products (UTMD) | United States | $0.193B | 17.02 |
| Vireo Growth (VREOF) | United States | $0.193B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Exagen (XGN) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.78 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Nephros (NEPH) | United States | $0.047B | 33.69 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.86 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |